IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Intec Pharma, Ltd.
Symbol: NTEC
Price: Last trade $8.36
Description: Their ordinary shares currently trade on the Tel Aviv Stock Exchange, or the TASE, under the symbol ‘INTP.’
Trade Date: Week of 7/27
Shares: 4.5 million
Underwriter(s) Maxim Group LLC, Roth Capital Partners
Rating=Subscription Needed
Company: CytRx Corporation
Symbol: CYTR
Price: Last trade $3.80
Trade Date: 7/21
Shares: 6.6 million
Underwriter(s) Jefferies
Rating=Subscription Needed
Company: Exact Sciences
Symbol: EXAS
Price: Last trade $27.03
Trade Date: 7/21
Shares: 7 million
Underwriter(s) Jefferies, Robert Baird & Co
Rating=Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish